Aman Amanullah, MD, PhD

Professor of Medicine

Aman Amanullah, MD, PhD

Contact

Jefferson Einstein Philadelphia Hospital
Philadelphia, PA

Email Aman Amanullah

215-456-8991
215-456-3533 fax

Featured Links

Aman Amanullah, MD, PhD

Professor of Medicine

Education

PhD, Karolinska Institute, Stockholm, Sweden - 1993

Medical School

MD, Carol Davila University of Medicine, Bucharest, Romania - 1979

Residency

Karolinska Institute at Stockholm South Hospital, (Södersjukhuset), Stockholm, Sweden - 1989

Fellowship

Cedars-Sinai Medical Center, Los Angeles, CA - 1997

Karolinska Institute at Stockholm South Hospital, (Södersjukhuset), Stockholm, Sweden - 1992

Publications

Board Certifications

  • Cardiovascular Diseases, American Board of Internal Medicine
  • National Board of Echocardiography
  • Certification Board of Nuclear Cardiology 

Awards

  • Philadelphia Magazine Top Doctors – Cardiology 2015-2024
  • Castle Connolly Top Doctor – 2013-2024
  • US News and World Reports – Top Doctor Cardiology 2013-2024
  • America’s Top Cardiologists – 2008-2024

Research & Clinical Interests

Dr. Amanullah’s research areas include noninvasive stress imaging modalities for the diagnosis and the prognosis of patients with known or suspected coronary artery disease. By factoring multiple variables for each patient, he developed statistical models that would predict the likelihood of severe cardiac events in a wide spectrum of patients with suspected or known coronary artery disease.

Other research areas include the incremental prognostic value of myocardial perfusion SPECT in women, the very elderly, and patients with diabetes mellitus. Dr. Amanullah’s areas of research also include multimodality imaging in transcatheter aortic valve replacement (TAVR), frailty status and survival after TAVR and surgical AVR. Dr. Amanullah is also working, using NIS (National Inpatient Sample) database the impact of COVID-19 on hospitalization outcomes of patients with acute myocardial infarction in the USA as well as impact of comorbid heart failure among hospitalized patients with sarcoidosis.